You are hereAugust 1, 2019
Liver transplants could be redundant with discovery of new liver cell
LONDON (UK), July 2019 — Scientists have identified a new type of cell called a hepatobiliary hybrid progenitor (HHyP) that forms during our early development in the womb. Surprisingly, HHyP also persists in small quantities in adults and these cells can grow into the two main cell types of the adult liver (hepatocytes and cholangiocytes) giving HHyPs stem cell-like properties.
The team examined HHyPs and found that they resemble mouse stem cells which have been found to rapidly repair mice liver following major injury, such as occurs in cirrhosis. They reported their findings in a paper published recently in Nature Communications.
“For the first time, we have found that cells with true stem cell-like properties may well exist in the human liver,” said lead author Tamir Rashid, M.D., Ph.D., from the Centre for Stem Cells & Regenerative Medicine at King’s College London. “This, in turn, could provide a wide range of regenerative medicine applications for treating liver disease, including the possibility of bypassing the need for liver transplants.”
Liver disease is the fifth biggest killer in the UK and the third most common cause of premature death, and the number of cases is continuing to rise. It can be caused by lifestyle issues such as obesity, viruses, alcohol misuse or by non-lifestyle issues such as autoimmune and genetic mediated disease.
Symptoms of liver disease include jaundice, itching and feelings of weakness and tiredness, and in more severe cases, cirrhosis. The only treatment for severe liver diseases at present is a liver transplant, which can lead to a lifetime of complications and for which the need for donor organs greatly outweighs the increasing demands.
“For the first time, we have found that cells with true stem cell-like properties may well exist in the human liver. This, in turn, could provide a wide range of regenerative medicine applications for treating liver disease, including the possibility of bypassing the need for liver transplants,” Dr Rashid.